Working together to advance the field of psilocybin-assisted psychotherapy shows promise for treating major depression
Innovations in care and research
The Ohio State University’s Neurological Institute, one of Columbus’ top programs for psychiatry and behavioral health, has over 200 medical, surgical and research specialists dedicated to the treatment of patients with neurological and psychiatric disorders.
Read about our latest clinical trials and research innovations taking place every day. Visit the Psychiatry and Behavioral Health Department website for more information.
How building a trauma-informed culture in the community and the workplace improves wellness
Early Psychosis Intervention Center offers specialized care for patients with or at risk for psychosis
Doctors are training the next addiction medicine workforce
How mental health disparities affect resilience and the impact of trauma
The collaborative care model of psychosocial oncology supports patients with breast cancer
Ohio State Sports Medicine prioritizes athletes’ mental health
Treating depression with innovative mindfulness-based cognitive therapy
Featured Stories
Neuroscientist launches resilience program to study trauma response
Treatment for adolescents and young adults with psychosis set to expand statewide
Exploring the intersection of trauma, addiction and the brain
Can advanced imaging technology reveal personalized neural treatment targets for depression?
Alcohol-related aggression: New therapies may result from Ohio State study
National expert to lead Ohio State study in firearm-related suicide
Treating advanced depression with stimulation therapies
Behavioral Health Immediate Care Program seeks to fill gaps in access to care
Tackling a pandemic within a pandemic
Screening program identifies cognitive, emotional aftereffects of severe COVID-19
Innovative behavioral health programs aimed at helping veteran
Showing care and compassion for caregivers during COVID-19
Ohio State supports trauma survivors with evidence-based, trauma-informed therapy and education
Ohio State integrates care for neurologic patients with related psychiatric symptoms
Ohio State researchers exploring mindfulness-based cognitive therapy to aid type 2 diabetes patients
Exploring the Effects of Maternal Stress on Offspring Brain Development
Evaluating Ketamine for Treatment-Resistant Depression
Building a Network to Address Opioid Issues
Leading the way
Ohio State Wexner Medical Center Among Nation’s Best in Nine Specialty Areas
Ohio State Welcomes Dr. Luan Phan, New Chair Department Psychiatry and Behavioral Health
$1.1 Million Grant Received for Early Psychosis Care
Investigating Neuroinflammation as Cause of Memory Decline in Older Adults
Addressing Opioid-Related Crises in Novel Ways
